Dolby Laboratories, Inc.
DLB
NYSE
67
USD+0.93(+1.41%)
As of today
Dolby Laboratories, Inc. fundamentals
Key ratios
Statements Highlights
| Period Ending | Sep 24, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 27, 2024 | Sep 26, 2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 1,281,256,000 | 1,253,793,000 | 1,299,744,000 | 1,273,721,000 | 1,349,130,000 | |
| Gross Profit | 1,151,231,000 | 1,112,433,000 | 1,147,178,000 | 1,133,225,000 | 1,188,998,000 | |
| Operating Income | 340,759,000 | 217,228,000 | 262,814,000 | 264,709,999 | 264,959,000 | |
| Net Income | 310,227,000 | 184,087,000 | 200,656,000 | 261,825,000 | 255,018,000 | |
| Total Assets | — | 2,702,173,000 | 2,994,564,000 | — | 3,227,760,000 | |
| Total Current Liabilities | — | 277,518,000 | 422,226,000 | — | 437,790,000 | |
| Total Equity | — | 2,251,020,000 | 2,372,184,000 | — | 2,631,946,000 | |
| Free Cash Flow | — | 259,120,000 | 336,742,000 | — | 430,257,000 | |
| Cash from Operations | — | 318,576,000 | 367,081,000 | — | 472,198,000 | |
| Cash from Investing | — | -295,935,000 | 54,206,000 | — | -10,586,000 | |
| Cash from Financing | — | -610,558,000 | -236,812,000 | — | -247,238,000 | |
| Net Change in Cash | — | -604,661,000 | 189,595,000 | — | 215,609,000 |